Vancomycin-Resistant Staphylococcus aureus (VRSA) Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Amprologix Ltd
CrystalGenomics Inc
Destiny Pharma Plc
Lysimmune BioScience
Sano Chemicals Inc
TAXIS Pharmaceuticals Inc
TGV-Inhalonix Inc
Therapeutic Systems Research Laboratories Inc
Wockhardt Ltd